These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38256877)

  • 21. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
    Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
    J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
    Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Ma L; Ai F; Xiao H; Wang F; Shi L; Bai X; Zhu Y; Ma W
    Front Pharmacol; 2024; 15():1367747. PubMed ID: 38576495
    [No Abstract]   [Full Text] [Related]  

  • 24. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
    Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoliquiritigenin Inhibits Interferon-γ-Inducible Genes Expression in Hepatocytes through Down-Regulating Activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt Signaling Pathways.
    Wu S; Xue J; Yang Y; Zhu H; Chen F; Wang J; Lou G; Liu Y; Shi Y; Yu Y; Xia C; Hu Y; Chen Z
    Cell Physiol Biochem; 2015; 37(2):501-14. PubMed ID: 26315837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
    Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent.
    Huang F; Wang J; Xu Y; Zhang Y; Xu N; Yin L
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 30. Isoliquiritigenin inhibits the proliferation, apoptosis and migration of osteosarcoma cells.
    Li C; Zhou X; Sun C; Liu X; Shi X; Wu S
    Oncol Rep; 2019 Apr; 41(4):2502-2510. PubMed ID: 30720124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer Effects of Fufang Yiliu Yin Formula on Colorectal Cancer Through Modulation of the PI3K/Akt Pathway and BCL-2 Family Proteins.
    Dong B; Yang Z; Ju Q; Zhu S; Wang Y; Zou H; Sun C; Zhu C
    Front Cell Dev Biol; 2020; 8():704. PubMed ID: 32850824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms underlying isoliquiritigenin-induced apoptosis and cell cycle arrest via ROS-mediated MAPK/STAT3/NF-κB pathways in human hepatocellular carcinoma cells.
    Wang JR; Luo YH; Piao XJ; Zhang Y; Feng YC; Li JQ; Xu WT; Zhang Y; Zhang T; Wang SN; Xue H; Wang WZ; Cao LK; Jin CH
    Drug Dev Res; 2019 Jun; 80(4):461-470. PubMed ID: 30698296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evodiamine Inhibits Colorectal Cancer Growth via RTKs Mediated PI3K/AKT/p53 Signaling Pathway.
    Zheng Q; Jing S; Hu L; Meng X
    J Cancer; 2024; 15(8):2361-2372. PubMed ID: 38495504
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of network pharmacology and transcriptomics to explore the mechanism of isoliquiritigenin in treating heart failure induced by myocardial infarction.
    Zhang L; Luan Y; Ding X; Yang C; Xing L; Zhang H; Liu Z
    Toxicol Appl Pharmacol; 2024 Nov; 492():117114. PubMed ID: 39357681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoliquiritigenin-mediated p62/SQSTM1 induction regulates apoptotic potential through attenuation of caspase-8 activation in colorectal cancer cells.
    Jin H; Seo GS; Lee SH
    Eur J Pharmacol; 2018 Dec; 841():90-97. PubMed ID: 30339814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation.
    Ma S; Guo X; Han R; Meng Q; Zhang Y; Quan W; Miao S; Yang Z; Shi X; Wang S
    Front Pharmacol; 2024; 15():1355644. PubMed ID: 38384287
    [No Abstract]   [Full Text] [Related]  

  • 38. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway.
    Zhang XR; Wang SY; Sun W; Wei C
    Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the mechanism of Erteng-Sanjie capsule in treating gastric and colorectal cancers via network pharmacology and in-vivo validation.
    Zhang W; Wang Y; Yu H; Jin Z; Yuan Y; Liu L; Zhou J
    J Ethnopharmacol; 2024 Jun; 327():117945. PubMed ID: 38428659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promethazine inhibits proliferation and promotes apoptosis in colorectal cancer cells by suppressing the PI3K/AKT pathway.
    Tan X; Gong L; Li X; Zhang X; Sun J; Luo X; Wang Q; Chen J; Xie L; Han S
    Biomed Pharmacother; 2021 Nov; 143():112174. PubMed ID: 34560542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.